Dodávky léků - REMSIMA II 2026
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
All submissions must be in Czech. Non-Czech speakers may face translation costs or errors.
Procurement documents (e.g., detailed specifications, contract terms) were not analyzed. Key requirements may be missin...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 56.2M estimated value
- Supplies contract
- 1 lot
- Supply of infliximab (L04AB02) for the Rheumatology Institute
- Continuous deliveries over 36 months
Show full summary
Open tender for the supply of infliximab (REMSIMA II 2026) to the Rheumatology Institute in Prague, Czech Republic. Single lot, 36-month framework with a total estimated value of 56,164,000 CZK. Award based solely on lowest price. Submission deadline: 13 July 2026.
Risks
All submissions must be in Czech. Non-Czech speakers may face translation costs or errors.
Procurement documents (e.g., detailed specifications, contract terms) were not analyzed. Key requirements may be missin...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Supply of infliximab (ATK code L04AB02)
- Contract duration: 36 months
Administrative
- Submission must be in Czech language only
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Revmatologický ústav
Location
Praha, CZE
Buyer profile
Identifier
00023728
Lots (1)
LOT-0001
Dodávky léků - REMSIMA II 2026
Continuous supply of infliximab (ATC L04AB02) as per the contractual annex. One lot covering all requirements.
CZK 56.2M
Estimated value
Location
Category
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem plnění jsou průběžné dodávky dle Přílohy č. 1 Kupní smlouvy – Cenová nabídka, v rozsahu a v souladu se zadávacími podmínkami a to dodávky léčivých přípravků infliximab – L04AB02.
Procurement Details
- Publication date
- 08 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 392956-2026
- Source notice ID
- 012e39e6-df13-4b61-aa0e-c30a0013f6c0
Documents (1)
Similar tenders
Czechia – Solar photovoltaic modules – Výstavba FVE na budově čističky odpadních vod ve Špindlerově Mlýně
Czechia – Cytometers – UK 1. LF – Průtokový cytometr – spektrální sorter
Czechia – Radio-isotopes – Dodávky radiofarmaka 18F – fludeoxyglukosum pro pozitronovou emisní tomografii.
Czechia – X-ray inspection equipment – UTB - Testovací laboratoř - FT - Vysokorychlostní rentgenový tomograf
Czechia – Medical consumables – Endoskopické vybavení pro gastroenterologii II
Czechia – Computer servers – ČSSZ – Pořízení serverů pro centrální provoz aplikací OSVČ II.
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
All submissions must be in Czech. Non-Czech speakers may face translation costs or errors.
Procurement documents (e.g., detailed specifications, contract terms) were not analyzed. Key requirements may be missin...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications